3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever |...

Published on 24 Feb 2025 on The Motley Fool

Plenty of them are even familiar names found within the S&P 500 index. There's no denying the...

Read the rest of the article

Start tracking your investments with Statfolio

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet,...

FierceBiotech 24 Feb 2025

Plenty of them are even familiar names found within the S&P 500 index. There's no denying the...

The Motley Fool 24 Feb 2025

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. I...

Insider Monkey · via Yahoo Finance 23 Feb 2025

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar ...

Motley Fool · via Yahoo Finance 22 Feb 2025

An outbreak of measles is wreaking havoc in the South Plains region of Texas, where nearly 60 chi...

The Hill · via Yahoo News 21 Feb 2025

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut shor...

Los Angeles Times 19 Feb 2025

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to...

FierceBiotech 19 Feb 2025

E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executiv...

Pharmaceutical Technology · via Yahoo Finance 19 Feb 2025

We recently compiled a list of the 13 Cheap High Dividend Stocks To Invest In Now. In this articl...

Insider Monkey · via Yahoo Finance 18 Feb 2025

On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s (NYSE:MRK) Welir...

Benzinga · via Yahoo Finance 18 Feb 2025